INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAC2
Intercept Pharmaceuticals In has 9 institutional holders in Filings Flow’s 13F database, together reporting 110.88M shares worth $103M as of Q4 2022. The largest reported holders are Deerfield Management Company, L.P., Wolverine Asset Management LLC, and Css LLC/Il.
Institutional Holders
9
Q4 2022
Reported Value
$103M
Ticker
unmapped
private placement or foreign
Quarters Tracked
1
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P.$8.5B AUM | 2.32% | $105M | 98.35M | Q3 2023 |
| CSS LLC/IL$2.1B AUM | 0.32% | $5M | 4.50M | Q3 2023 |
| Graham Capital Management, L.P.$4.1B AUM | 0.13% | $4M | 4.50M | Q2 2023OLDER |
| WOLVERINE ASSET MANAGEMENT LLC$10.4B AUM | 0.09% | $8M | 7.79M | Q3 2023 |
| LAZARD ASSET MANAGEMENT LLC$60.8B AUM | 0.01% | $4,602 | 4.50M | Q4 2022OLDER |
| Man Group plc$55.1B AUM | 0.00% | $843,563 | 825.0K | Q4 2022OLDER |
| AMERICAN CENTURY COMPANIES INC$194.3B AUM | 0.00% | $99,207 | 97.0K | Q4 2022OLDER |
| Bank of New York Mellon Corp$543.9B AUM | 0.00% | $291,549 | 300.0K | Q4 2022OLDER |
| JANE STREET GROUP, LLC$777.2B AUM | 0.00% | $64,219 | 60.0K | Q3 2023 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.